You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COM-B

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

Recruiting
  • Hemophilia B
  • Sodium valproate extended-release tablets
  • Beijing, China
    PLA General Hospital
Jun 17, 2023

B-cell Acute Lymphoblastic Leukemia (B-ALL) Trial in Worldwide (AZD0486)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia (B-ALL)
  • Duarte, California
  • +30 more
Nov 13, 2023

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Hepatitis B, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

Not yet recruiting
  • Hepatitis B
  • +2 more
  • Patient Participation Form
  • (no location specified)
Mar 3, 2023

Contribution of Psychological Autopsy to Understanding of

Not yet recruiting
  • Suicide, Mental Disorders and Socio-health Profile of Suicided Persons
  • other
  • Fort-De-France, France, Martinique
    Centre Hospitalier Universitaire de Martinique - Hôpital Pierre
Mar 7, 2023

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma Trial in China (Relmacabtagene

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Relmacabtagene Autoleucel
  • +2 more
  • Guangzhou, Guangdong, China
  • +12 more
Oct 24, 2023

Exercise Movement Techniques, Exercise Therapy, Hamstring Injury Trial in Faisalabad (Progressive eccentric exercises,

Recruiting
  • Exercise Movement Techniques
  • +2 more
  • Progressive eccentric exercises
  • Bodyweight exercises
  • Faisalabad, Punjab, Pakistan
    Alfateh sports complex
Nov 9, 2023

Healthy Participants Trial in Tempe (Aficamten, Aficamten-matching Placebo, Moxifloxacin)

Recruiting
  • Healthy Participants
  • Tempe, Arizona
    Celerion, Inc 2420
Jun 27, 2023

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Telitacicept on Transitional Regulatory B Cells in Systemic

Recruiting
  • Telitacicept
  • +2 more
    • Jinan, Shandong, China
      Yanfeng Hou
    Nov 19, 2023

    Basilar Invagination, Prospective Study, Surgical Outcome Trial in Beijing (Posterior fossa decompression, Posterior

    Not yet recruiting
    • Basilar Invagination
    • +2 more
    • Posterior fossa decompression
    • Posterior Compression-Distraction-Reduction-Fixation
    • Beijing, Beijing, China
      Xuanwu Hospital
    May 6, 2023

    Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

    Not yet recruiting
    • Advanced Solid Tumors
    • B-cell Non-Hodgkin Lymphomas
    • (no location specified)
    Aug 31, 2023

    Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

    Recruiting
    • Chronic Hepatitis b
    • Non-Alcoholic Fatty Liver Disease
      • Beijing, Select A State Or Province, China
        Yameng Sun
      Mar 27, 2023

      Relapsed or Refractory B-cell Lymphoma Trial in Shanghai (SR-GDP)

      Not yet recruiting
      • Relapsed or Refractory B-cell Lymphoma
      • Shanghai, Shanhai, China
        Ruijin Hospital
      Sep 29, 2023

      Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory Trial in Hangzhou (Anlotinib HCl, Rituximab,

      Recruiting
      • Diffuse Large B-cell Lymphoma Recurrent
      • Diffuse Large B Cell Lymphoma Refractory
      • Anlotinib hydrochloride, Rituximab, gemcitabine, oxaliplatin
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Oct 12, 2023

      Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

      Not yet recruiting
      • Advanced Malignancies
      • 1A46 Drug Substance
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Aug 4, 2023

      Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

      Recruiting
      • Diffuse Large B-cell Lymphoma
      • Metabolically Armed CD19 CAR-T cells
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Nov 1, 2023

      Iliotibial Band Syndrome, Pain, Flexibility Trial in Faisalabad (Functional motor control excercise, convectional excercise)

      Recruiting
      • Iliotibial Band Syndrome
      • +2 more
      • Functional motor control excercise
      • convectional excercise
      • Faisalābad, Punjab, Pakistan
        Jawad Club
      Nov 9, 2023

      CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

      Recruiting
      • CAR
      • +2 more
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Dec 27, 2022

      Solid Tumor, Adult Trial in Wuxi (177Lu-B5-IgG4)

      Not yet recruiting
      • Solid Tumor, Adult
      • Wuxi, Jiangsu, China
        Affiliated Hospital of Jiangnan University
      Nov 20, 2022

      Characterize Effectiveness and Safety of HEMGENIX® in Hemophilia

      Not yet recruiting
      • Hemophilia B
      • HEMGENIX
      • Factor IX (FIX)
      • (no location specified)
      Aug 23, 2023

      Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in

      Not yet recruiting
      • Non-Hodgkin Lymphoma, B-cell
      • "novel" MAB (alone or in combination)
      • Viagrande, Catania, Italy
      • +57 more
      Aug 18, 2023

      Healthy, Type 2 Diabetes Trial in United States (LY3938577, Placebo, Insulin degludec)

      Not yet recruiting
      • Healthy
      • Type 2 Diabetes Mellitus
      • Anaheim, California
      • +3 more
      Nov 10, 2023